These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 34320520)

  • 1. Positive effects of roflumilast on behavior, neuroinflammation, and white matter injury in mice with global cerebral ischemia.
    Vilhena ER; Bonato JM; Schepers M; Kunieda JKC; Milani H; Vanmierlo T; Prickaerts J; de Oliveira RMW
    Behav Pharmacol; 2021 Sep; 32(6):459-471. PubMed ID: 34320520
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Roflumilast promotes memory recovery and attenuates white matter injury in aged rats subjected to chronic cerebral hypoperfusion.
    Santiago A; Soares LM; Schepers M; Milani H; Vanmierlo T; Prickaerts J; Weffort de Oliveira RM
    Neuropharmacology; 2018 Aug; 138():360-370. PubMed ID: 29933009
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Phosphodiesterase-4 Inhibitor Roflumilast, a Potential Treatment for the Comorbidity of Memory Loss and Depression in Alzheimer's Disease: A Preclinical Study in APP/PS1 Transgenic Mice.
    Wang H; Zhang FF; Xu Y; Fu HR; Wang XD; Wang L; Chen W; Xu XY; Gao YF; Zhang JG; Zhang HT
    Int J Neuropsychopharmacol; 2020 Dec; 23(10):700-711. PubMed ID: 32645141
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Roflumilast ameliorates cognitive impairment in APP/PS1 mice via cAMP/CREB/BDNF signaling and anti-neuroinflammatory effects.
    Feng H; Wang C; He W; Wu X; Li S; Zeng Z; Wei M; He B
    Metab Brain Dis; 2019 Apr; 34(2):583-591. PubMed ID: 30610438
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Roflumilast protects against spatial memory impairments and exerts anti-inflammatory effects after transient global cerebral ischemia.
    Bonato JM; Meyer E; de Mendonça PSB; Milani H; Prickaerts J; Weffort de Oliveira RM
    Eur J Neurosci; 2021 Feb; 53(4):1171-1188. PubMed ID: 33340424
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Roflumilast ameliorates cognitive deficits in a mouse model of amyloidogenesis and tauopathy: Involvement of nitric oxide status, Aβ extrusion transporter ABCB1, and reversal by PKA inhibitor H89.
    Ashour NH; El-Tanbouly DM; El Sayed NS; Khattab MM
    Prog Neuropsychopharmacol Biol Psychiatry; 2021 Dec; 111():110366. PubMed ID: 34051306
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuroprotective effect of roflumilast under cerebral ischaemia/reperfusion injury in juvenile rats through NLRP-mediated inflammatory response inhibition.
    Keskin H; Keskin F; Tavaci T; Halici H; Yuksel TN; Ozkaraca M; Bilen A; Halici Z
    Clin Exp Pharmacol Physiol; 2021 Aug; 48(8):1103-1110. PubMed ID: 33686709
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phosphodiesterase 4 Inhibitor Roflumilast Protects Rat Hippocampal Neurons from Sevoflurane Induced Injury via Modulation of MEK/ERK Signaling Pathway.
    Peng S; Yan HZ; Liu PR; Shi XW; Liu CL; Liu Q; Zhang Y
    Cell Physiol Biochem; 2018; 45(6):2329-2337. PubMed ID: 29550808
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PDE4 inhibition reduces neointima formation and inhibits VCAM-1 expression and histone methylation in an Epac-dependent manner.
    Lehrke M; Kahles F; Makowska A; Tilstam PV; Diebold S; Marx J; Stöhr R; Hess K; Endorf EB; Bruemmer D; Marx N; Findeisen HM
    J Mol Cell Cardiol; 2015 Apr; 81():23-33. PubMed ID: 25640159
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The glucose-lowering effects of the PDE4 inhibitors roflumilast and roflumilast-N-oxide in db/db mice.
    Vollert S; Kaessner N; Heuser A; Hanauer G; Dieckmann A; Knaack D; Kley HP; Beume R; Weiss-Haljiti C
    Diabetologia; 2012 Oct; 55(10):2779-2788. PubMed ID: 22790061
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An experimental medicine study of the phosphodiesterase-4 inhibitor, roflumilast, on working memory-related brain activity and episodic memory in schizophrenia patients.
    Gilleen J; Farah Y; Davison C; Kerins S; Valdearenas L; Uz T; Lahu G; Tsai M; Ogrinc F; Reichenberg A; Williams SC; Mehta MA; Shergill SS
    Psychopharmacology (Berl); 2021 May; 238(5):1279-1289. PubMed ID: 30536081
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The preclinical pharmacology of roflumilast--a selective, oral phosphodiesterase 4 inhibitor in development for chronic obstructive pulmonary disease.
    Hatzelmann A; Morcillo EJ; Lungarella G; Adnot S; Sanjar S; Beume R; Schudt C; Tenor H
    Pulm Pharmacol Ther; 2010 Aug; 23(4):235-56. PubMed ID: 20381629
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of tadalafil (PDE5 inhibitor) and roflumilast (PDE4 inhibitor) on airway reactivity and markers of inflammation in ovalbumin-induced airway hyperresponsiveness in guinea pigs.
    Mokry J; Urbanova A; Medvedova I; Kertys M; Mikolka P; Kosutova P; Mokra D
    J Physiol Pharmacol; 2017 Oct; 68(5):721-730. PubMed ID: 29375047
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PDE4 inhibitor, roflumilast protects cardiomyocytes against NO-induced apoptosis via activation of PKA and Epac dual pathways.
    Kwak HJ; Park KM; Choi HE; Chung KS; Lim HJ; Park HY
    Cell Signal; 2008 May; 20(5):803-14. PubMed ID: 18276108
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preliminary evidence for the phosphodiesterase type-4 inhibitor, roflumilast, in ameliorating cognitive flexibility deficits in patients with schizophrenia.
    Livingston NR; Hawkins PC; Gilleen J; Ye R; Valdearenas L; Shergill SS; Mehta MA
    J Psychopharmacol; 2021 Sep; 35(9):1099-1110. PubMed ID: 33908296
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential effects of two phosphodiesterase 4 inhibitors against lipopolysaccharide-induced neuroinflammation in mice.
    Kang DH; Ahn S; Chae JW; Song JS
    BMC Neurosci; 2023 Jul; 24(1):39. PubMed ID: 37525115
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Roflumilast, a Phosphodiesterases-4 (PDE4) Inhibitor, Alleviates Sepsis‑induced Acute Kidney Injury.
    Xu X; Liao L; Hu B; Jiang H; Tan M
    Med Sci Monit; 2020 May; 26():e921319. PubMed ID: 32449901
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Roflumilast attenuates cognitive deficits in estrogen insufficient rats.
    Goyal A; Garabadu D
    Behav Pharmacol; 2020 Oct; 31(7):671-687. PubMed ID: 32516271
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Roflumilast Suppresses Adipogenic Differentiation 
    Xu W; Zhang J; Xiao J
    Front Endocrinol (Lausanne); 2021; 12():662451. PubMed ID: 34163436
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The phosphodiesterase-4 inhibitor roflumilast decreases ethanol consumption in C57BL/6J mice.
    Liu X; Hao PD; Yang MF; Sun JY; Mao LL; Fan CD; Zhang ZY; Li DW; Yang XY; Sun BL; Zhang HT
    Psychopharmacology (Berl); 2017 Aug; 234(16):2409-2419. PubMed ID: 28477089
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.